New Report Cautions Pharma that a Big Budget Does Not Always Equate to a High-Performing Launch

Trinity Life Sciences Assesses Pharma/Biotech Commercial Performance Trends

New Assessment Identifies the High-Risk Functions Within Pharma that are Least Prepared for Challenges Ahead

Forty Percent of Healthcare Providers Across a Wide Range of Specialties are Using More Telemedicine Than Before COVID-19

Trinity Life Sciences Names Peter Hoenigsberg to its Board of Directors

U.S. Physicians Still Willing to Participate in Healthcare Market Research During Coronavirus Pandemic

Trinity Life Sciences Offers Digital Approach to Understanding the Patient Journey

Trinity Life Sciences Monitors Coronavirus Impact on Biopharm Operations

Trinity Life Sciences Introduces the First and Only End-to-End Market Access Solution for Biopharma

Trinity Life Sciences Continues to See Inflective Growth in Health Economics and Outcomes Research Practice